Kadmon Holdings Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 127

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 12

  • Investments
  • 4

Kadmon Holdings General Information

Description

Kadmon Holdings Inc is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of small molecules and biologics with a focus on inflammatory and fibrotic diseases. Its pipeline products include Belumosudil (KD025) and KD033.

Contact Information

Website
www.kadmon.com
Formerly Known As
Kadmon Holdings, Llc, Kadmon I Llc
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 450 East 29th Street
  • New York, NY 10016
  • United States
+1 (212)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Sanofi
Vertical(s)
Corporate Office
  • 450 East 29th Street
  • New York, NY 10016
  • United States
+1 (212)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Kadmon Holdings Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Kadmon Holdings‘s full profile, request access.

Request a free trial

Kadmon Holdings Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Kadmon Holdings Inc is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commerciali
Drug Discovery
New York, NY
127 As of 2020

Cambridge, MA
 

Amsterdam, Netherlands
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Kadmon Holdings Competitors (8)

One of Kadmon Holdings’s 8 competitors is Sarepta Therapeutics, a Formerly VC-backed company based in Cambridge, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Sarepta Therapeutics Formerly VC-backed Cambridge, MA
uniQure Formerly VC-backed Amsterdam, Netherlands
Genetix Biotherapeutics Private Equity-Backed Somerville, MA
Sangamo Therapeutics Formerly VC-backed Richmond, CA
BioCryst Pharmaceuticals Corporation Durham, NC
You’re viewing 5 of 8 competitors. Get the full list »

Kadmon Holdings Patents

Kadmon Holdings Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026165001-A1 Combination therapy comprising belumosudil and gusacitinib Pending 28-Jan-2025
WO-2026161860-A1 Dosing of immunocytokines for cancer treatment Pending 27-Jan-2025
WO-2025184133-A1 Methods of treating chronic graft versus host disease with belumosudil after ceasing administration of ruxolitinib Pending 29-Feb-2024
US-20260315475-A1 Method of administering belumosudil for patent subpopulations with hepatic impairment Pending 21-Nov-2023
WO-2025110992-A1 Method of administering belumosudil for patient subpopulations with hepatic impairment Inactive 21-Nov-2023 A61K31/517
To view Kadmon Holdings’s complete patent history, request access »

Kadmon Holdings Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Kadmon Holdings Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Kadmon Holdings‘s full profile, request access.

Request a free trial

Kadmon Holdings Investments & Acquisitions (4)

Kadmon Holdings’s most recent deal was a Joint Venture with Joint Venture (Kadmon Holdings / Meiji Seika Pharma Co.). The deal was made on 26-Dec-2019.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Joint Venture (Kadmon Holdings / Meiji Seika Pharma Co.) 26-Dec-2019 Joint Venture Drug Discovery
BK Pharmaceuticals 07-Nov-2019 Joint Venture Pharmaceuticals
Three Rivers Pharmaceuticals 25-Oct-2010 Merger/Acquisition Pharmaceuticals
PhytoCeutica 24-Oct-2010 Merger/Acquisition Biotechnology
To view Kadmon Holdings’s complete investments and acquisitions history, request access »

Kadmon Holdings FAQs

  • When was Kadmon Holdings founded?

    Kadmon Holdings was founded in 2009.

  • Where is Kadmon Holdings headquartered?

    Kadmon Holdings is headquartered in New York, NY.

  • What is the size of Kadmon Holdings?

    Kadmon Holdings has 127 total employees.

  • What industry is Kadmon Holdings in?

    Kadmon Holdings’s primary industry is Drug Discovery.

  • Is Kadmon Holdings a private or public company?

    Kadmon Holdings is a Private company.

  • What is the current valuation of Kadmon Holdings?

    The current valuation of Kadmon Holdings is .

  • What is Kadmon Holdings’s current revenue?

    The current revenue for Kadmon Holdings is .

  • How much funding has Kadmon Holdings raised over time?

    Kadmon Holdings has raised $129M.

  • Who are Kadmon Holdings’s investors?

    72 KDMN Investment, Aeon Group (Miami), GoldenTree Asset Management, Jiangsu Tech Industry Investment, and Palkon Capital Management are 5 of 9 investors who have invested in Kadmon Holdings.

  • Who are Kadmon Holdings’s competitors?

    Sarepta Therapeutics, uniQure, Genetix Biotherapeutics, Sangamo Therapeutics, and BioCryst Pharmaceuticals are some of the 8 competitors of Kadmon Holdings.

  • When was Kadmon Holdings acquired?

    Kadmon Holdings was acquired on 09-Nov-2021.

  • Who acquired Kadmon Holdings?

    Kadmon Holdings was acquired by Sanofi.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process